Yu-Feng Xing (Yufeng Xing)

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 7

Top Topics

Combination Therapy

Systematic Review

Respiratory Syndrome Coronavirus

Lipopolysaccharide Induced

Top Venues

Journal of chemical information and modeling

BioMed research international

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Rong Yang, Linhua Liu, Dansheng Jiang, Lei Liu, Huili Yang, Hongling Xu, Meirong Qin, Ping Wang, Jiangyong Gu, Yu-Feng Xing
Identification of Potential TMPRSS2 Inhibitors for COVID-19 Treatment in Chinese Medicine by Computational Approaches and Surface Plasmon Resonance Technology. Journal of chemical information and modeling 63 (10) (2023)
Rong Yang, Linhua Liu, Dansheng Jiang, Lei Liu, Huili Yang, Hongling Xu, Meirong Qin, Ping Wang, Jiangyong Gu, Yu-Feng Xing
Identification of Potential TMPRSS2 Inhibitors for COVID-19 Treatment in Chinese Medicine by Computational Approaches and Surface Plasmon Resonance Technology. Journal of chemical information and modeling (2023)
Rong Yang, Linhua Liu, Dansheng Jiang, Lei Liu, Huili Yang, Hongling Xu, Meirong Qin, Ping Wang, Jiangyong Gu, Yu-Feng Xing
Identification of Potential TMPRSS2 Inhibitors for COVID-19 Treatment in Chinese Medicine by Computational Approaches and Surface Plasmon Resonance Technology. Journal of chemical information and modeling 63 (10) (2023)
Liubin Xu, Huili Yang, Hongling Xu, Rong Yang, Lian Fen, Dansheng Jiang, Linyi Xu, Yu-Feng Xing
Efficacy and safety of acetyl-CoA carboxylase (ACC) inhibitors in the treatment of nonalcoholic steatohepatitis (NASH): A protocol for systematic review. Medicine 101 (50) (2022)
Huili Yang, Lian Feng, Linyi Xu, Dansheng Jiang, Fenfen Zhai, Guangdong Tong, Yu-Feng Xing
Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut-Liver Axis. BioMed research international 2022 (2022)
Liubin Xu, Huili Yang, Hongling Xu, Rong Yang, Lian Fen, Dansheng Jiang, Linyi Xu, Yu-Feng Xing
Efficacy and safety of acetyl-CoA carboxylase (ACC) inhibitors in the treatment of nonalcoholic steatohepatitis (NASH): A protocol for systematic review. Medicine 101 (50) (2022)
Yu-Feng Xing, Zhen Zhang, Wen-Jun Fu, Da-Qiao Zhou, Ailsa Chui-Ying Yuen, Daniel Kam-Wah Mok, Chi-On Chan, Guang-Dong Tong
Shugan Xiaozhi Decoction Attenuates Nonalcoholic Steatohepatitis by Enhancing PPARα and L-FABP Expressions in High-Fat-Fed Rats. Evidence-based complementary and alternative medicine : eCAM 2016 (2016)